Introduction
Obesity is a risk factor for coronary artery disease (CAD) through its effects on glycemia, blood pressure, triglycerides and high-density lipid (HDL) cholesterol levels and inflammatory cytokines [1, 2] . Smoking is a major CAD risk factor, which also affects body weight [3] [4] [5] . Smokers weigh less than never smokers and gain weight after smoking cessation [6] [7] [8] [9] . They often have unhealthy dietary habits that could affect both body weight and CAD risk [10] [11] [12] [13] [14] . Thus, it is not surprising that the relation between body weight and CAD is strongly influenced by smoking status.
Earlier studies have shown a J-shaped relation between body mass index (BMI) and cardiovascular mortality, which is partially explained by the higher prevalence of smokers among lean individuals [15, 16] . When assessing the association between BMI and CAD incidence, adjustment for tobacco exposure does not fully control the complexity of the relation between smoking and adiposity, possibly resulting in an underestimation of the association [17, 18] . Thus, most recent studies have analysed separately the association between BMI and CAD mortality, in current smokers, former smokers and never smokers, respectively [15, 16] .
Abdominal obesity is an important risk factor for CAD [19] . Like BMI, the relation between abdominal obesity and CAD may be influenced by tobacco exposure. The extent to which tobacco exposure influences the effect of abdominal adiposity on CAD incidence remains uncertain [20] . Therefore, the goal of this study was to assess whether tobacco exposure affects CAD risk associated with abdominal obesity.
Methods
Cohort recruitment and examination methods have been described previously [21] . Briefly, the PRIME Study (Prospective Epidemiological Study of Myocardial Infarction) was established in 1991 in the populations of four collaborating WHO-MONICA centres in Belfast (United Kingdom), Lille, Strasbourg and Toulouse (France). The target was to recruit 2500 men, aged 50-59 years, in each centre. Finally, 10 602 men were recruited and followed during 10 years. Self-administered questionnaires related to demographic, socioeconomic factors and diet were completed at home by the participants and checked with the participants by survey staff at the clinic. The Ethics committee of the coordinating centre approved the protocol and all participants signed an informed consent before participation to the study.
Data on educational level, occupational activity, personal and family history, tobacco and alcohol consumption, drug intake and physical activity were also collected. Physical activity was assessed for work and leisure times, on working days and at weekends. Participants were classified into three categories: (i) regular physical exercise; (ii) moderate physical activity; and (iii) no physical activity. Smoking habits were determined from questions on present and past habits, number and type of cigarettes, cigars or pipe smoked/day. Current smokers were defined as individuals currently smoking at least one cigarette/day. Alcohol consumption was assessed by a questionnaire in which the participant reported his average consumption (in units) of wine, beer, cider and spirits for each day of the week. Intake of alcohol was expressed in millilitres of pure ethanol/week.
Personal medical history of cardiovascular risk factors was ascertained by asking the participant whether a medical doctor had ever reported a given risk factor, followed by questions on past and actual treatment. Accordingly, diabetes was defined by a positive personal medical history of diabetes and current blood glucose lowering therapy by dietary or pharmacological means. During an examination, the questionnaire on personal medical history was completed along with the London School of Hygiene Cardiovascular (Rose) Questionnaire for Chest Pain on Effort and Possible Infarction, and a standard 12-lead electrocardiogram was also recorded.
The anthropometric measurements included weight, height, waist circumference (WC) and hip circumference (to the nearest 0.5 cm), measured halfway between the lower ribs and the iliac crest for the WC and above the buttocks for the hip circumference on a participant in light clothing. BMI and waist to hip ratio (WHR) were calculated. Blood pressure was measured once at the end of the examination after a 5 min rest in the sitting position. Measurements were performed with an automatic device (Spengler SP9; Spengler, Cachan, France) that also recorded heart rate. A standard cuff size was used, but a large cuff was available when necessary. Hypertension was defined by systolic blood pressure greater than or equal to 140 mmHg and/or diastolic blood pressure greater than or equal to 90 mmHg and/or current blood pressure-lowering treatment.
Follow up
Criteria for diagnosis of coronary heart disease on followup have been described previously [22] . Briefly, participants were contacted annually by letter and asked to complete a clinical event questionnaire to be returned to the centre in a prepaid envelope. If a participant did not comply, phone contact was established with him or with his family doctor. For all participants reporting a possible event, clinical information was sought directly from the hospital or family doctor's notes. All details of electrocardiograms, hospital admissions, enzymes, surgical operations, angioplasty, treatment etc. were collected. Death certificates were checked for supporting clinical and postmortem information on cause of death. When necessary, the circumstances of death were obtained from the family doctor or the family. Of the initial 10 602 participants, 823 were excluded because of a previous history of CAD and 16 for missing WC, leaving 9763 participants. An independent medical committee, comprising members from each PRIME Centre and three independent cardiologists (two from France and one from the UK) ascertained events. During follow-up the incident events were: 221 effort angina, 450 acute coronary events (fatal and nonfatal myocardial infarction, sudden death and unstable angina) and 659 total CAD events.
Biology
Venous blood was collected after a 10-h fast into siliconised vacutainer tubes (Vacutainer; Becton Dickinson, Le Pont de Claix, France) containing EDTA. Aliquots of plasma were immediately transferred into plastic tubes and frozen at -801C. The frozen aliquots were then shipped in batches to the Central Laboratory in Lille. Plasma total cholesterol, triglyceride and HDL-cholesterol levels were measured by enzymatic methods using reagents from Boehringer Mannheim (Mannheim, Germany). Lowdensity lipid (LDL) cholesterol was assessed according to Friedewald's formula.
Statistical analysis
Statistical analysis was conducted using SAS 8.02 (SAS Institute, Cary, North Carolina, USA). The general linear model procedure and w 2 test were used to compare mean values of coronary risk factor levels and their distribution among waist circumference tertiles. Post-hoc analyses were performed using the lsmeans procedure of SAS. Poisson regression was used to calculate age and centreadjusted incidence rates of CAD events and their 95% confidence intervals. Cox proportional hazard models were used to assess the relation between anthropometric markers and CAD risk. Using log-log cumulative hazard plots and graphical and statistical procedures based on Schoenfeld residuals allowed us to exclude any departure from the proportional hazard hypothesis. Interactions were tested using the log likelihood method.
Results Table 1 presents baseline characteristics and CAD risk factors by WC tertiles. All parameters were significantly associated with waist circumference. Age, anthropometric measurements (BMI and WHR), alcohol intake, diabetes, blood pressure (systolic and diastolic) and lipid levels (cholesterol, LDL-cholesterol and triglycerides) increased across WC tertiles. In contrast, smoking, physical activity, educational level and HDL-cholesterol decreased across WC tertiles. Table 2 presents CAD risk factors by tobacco exposure categories. The mean duration of tobacco exposure was 36 and 23 years for current and former smokers. Among smokers, the mean number of cigarettes currently consumed was 14/day. Among former smokers, the average duration of smoking cessation was 14 years. The mean BMI, WC and WHR were higher in former smokers than in never smokers. Similarly, the mean alcohol intake, blood pressure (systolic and diastolic), total and LDLcholesterol and triglycerides were higher in former smokers than never smokers. In contrast, there was no statistical difference in mean age, physical activity, educational level, diabetes prevalence and mean HDLcholesterol between former and never smokers. The mean WHR, alcohol intake, total cholesterol and triglyceride levels (P < 0.0001) were higher, and mean age, BMI, physical activity, diastolic blood pressure and HDL-cholesterol levels were lower in current smokers than never smokers. In contrast, there was no difference in WC, educational level, diabetes prevalence, systolic blood pressure and LDL-cholesterol levels between current and never smokers. Figure 1 presents CAD incidence rates adjusted on age and centre by WC tertiles in never smokers, former smokers and current smokers. Regardless of WC tertiles, CAD incidence rates were higher in current smokers when compared with former smokers and never smokers. In each tobacco exposure strata there was a graded increase in CAD incidence across WC tertiles. Table 3 presents the adjusted relative risk (RR) (95% confidence intervals) of total CAD for one standard deviation (SD) increase of BMI (3.44 kg/m 2 ), WC (9.9 cm) and WHR (0.06) in never smokers, former smokers and current smokers. The RR associated with BMI tended to be lower in former and current smokers (interaction P = 0.07). In contrast, the RR of CAD associated with WC and WHR were not statistically different among smoking status groups. Further adjustment for diabetes, hypertension, LDL-cholesterol, HDL-cholesterol and triglycerides resulted in a loss of statistical significance in all smoking status strata.
Discussion
The results of this study showed that WC, a marker of abdominal adiposity, is associated with an increased risk of CAD in never, former and current smokers. This association, although lower in current than never smokers, is not statistically different among smoking status Abdominal obesity and smoking Chouraki et al. 627
categories. Therefore, it seems that smoking has limited impact on the association between WC and CAD. This suggests that abdominal adiposity seems to have a similar deleterious impact on coronary risk in never, former and current smokers.
Few prospective studies have analysed separately the relation between abdominal adiposity and CAD risk in current, former and never smokers. In the Paris Prospective Study, the RRs of cardiovascular death for increased sagittal diameter were similar to never smokers and ever smokers [20] . In the Interheart study, higher odds ratios of myocardial infarction were observed in current and former smokers than in never smokers [1] .
Other investigations have reported associations between abdominal adiposity indicators and all causes of mortality independent of tobacco exposure [23, 24] in never smokers only [25] . The results of this study, performed in a homogeneous group of men, aged 50-59 years, suggest that smoking status has little influence on CAD risk associated with increased abdominal adiposity. The difference with the results of the Interheart study might be related to the fact that the latter case-control study was conducted in men and women who present different CAD risk and body fat distribution. Furthermore, patients of the Interheart study belong to different ethnic origin, which may affect the relation between smoking, adiposity and CAD risk.
Earlier studies have shown that smoking tends to attenuate the relation between BMI and CAD risk [15, 16] . In agreement with these earlier reports, the RR of CAD associated with BMI was slightly attenuated in current smokers. The reasons for this observation might be that, among smokers, leanness might be associated with greater tobacco intoxication. In contrast, leanness could reflect better physical fitness or low fat intake resulting in reduced CAD events. Altogether these results show that smoking tends to attenuate the RR of CAD associated with increased BMI, a finding that is not observed for waist circumference and WHR.
CAD incidence rates were elevated in current smokers, low in never smokers and intermediate in former smokers. These results are in agreement with earlier data showing, after an initial rapid decline, a residual risk of coronary events long after smoking cessation [5, 6, 26] . In the Nurses' Health Study, RR of cardiovascular mortality was slightly higher after 10-14 years of smoking cessation than in never smokers [26] . In the Interheart study, a 22% excess risk was observed in those who quit smoking for more than 20 years compared with never smokers [5] . Among the possible explanation to the intermediate risk in former smoker, it might be possible that some former smokers relapsed into smoking. Alternatively, long-term smoke exposure could result in more permanent vascular damage resulting from BMI, body mass index; BP, blood pressure; HDL, high-density lipids; LDL, lowdensity lipids; WHR, waist-to-hip ratio. Mean (SD) or n (%). P values adjusted on age and centre; Post-hoc comparison with never smokers. ***P < 0.0001; **P < 0.01; *P < 0.05. oxidants-antioxidants imbalance, low-grade inflammation or haemostasis disturbances and characterised by endothelial and vascular lesions that may persist long after smoking cessation [27] . The results of this study also give some clues to the expected benefits of smoking cessation. The incidence of CAD, although increasing across WC tertiles, does not reach the level of current smokers. Thus, one can expect that smoking cessation, even associated with increased WC, results in a lower risk than being exposed to tobacco. Further, benefit may be expected if smoking cessation is not associated with increased body weight.
This study has several limitations. It was conducted in Caucasian men only, aged 50-59 years, restricting the conclusions to this subgroup of the population. Participation in the study was voluntary and a 'healthy worker effect' cannot be excluded. This effect is, however, not likely to be important for coronary event rates as the latter were comparable with those of the population register of the same area [22] . The study design allowed for many statistical adjustments but residual confounding owing to unmeasured factors or measurement errors cannot be ruled out. In addition, smoking status was determined only once at inclusion. It might be possible that, some former smokers relapsed into smoking and inversely some current smokers stopped smoking during the follow-up, resulting in a weakening of the observed associations between WC and CAD risk. Finally, although there were 659 well-defined CAD incident events this might still be insufficient to detect subtle effects of tobacco exposure on CAD risk and obesity.
In conclusion, despite important and complex effects of smoking on body fat distribution and CAD risk, the association between abdominal obesity and CAD risk seems to be homogenous across the different smoking exposure categories. Therefore, smokers with abdominal obesity are at high absolute risk of CAD. Smoking cessation is a priority in primary and secondary prevention of coronary events. Our results suggest that to maximise the absolute risk reduction, smoking cessation should be achieved avoiding an increase in abdominal adiposity. This hypothesis, however, needs confirmation in an appropriate prevention trial. 
